Dr. Robert Edward McCabe, MD

Dr. McCabe practices at All Saints Subacute & Rehabilitation Center in Ashland, California.

Dr. McCabe's NPI, 1073586905, was assigned on February 10, 2006. Dr. McCabe graduated from Harvard Medical School in 1976. Dr. McCabe holds California license G43724.

Dr. McCabe's primary practice is All Saints Subacute & Rehabilitation Center, at 1652 Mono Ave, Ashland, CA 94578 in Alameda County. The practice phone is (510) 481-3200.

Dr. McCabe's primary practice is All Saints Subacute & Rehabilitation Center in Ashland, California. Dr. McCabe is also affiliated with Alameda Health System - Highland Hospital. The medical group on file is Alameda Health System. Dmand AI also links Dr. McCabe to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCabe practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. McCabe's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. McCabe is board certified in infectious disease by the American Board of Internal Medicine. Dr. McCabe is licensed in California.

CMS data shows 2,657 Medicare services from Dr. McCabe across 7 procedure codes in 2024, for 391 Medicare patients. Medicare paid $243,080 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 391 Medicare patients who saw Dr. McCabe in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 84% are also on Medicaid. Their average risk score is 3.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McCabe's median patient age at 61, with 39% women.

In 2024, Dr. McCabe wrote 147 Medicare Part D claims for 38 patients. 79% of them were for generic drugs. CMS names the drug for 73 of them, across 5 drugs with 11 or more claims each, at $15,447 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. McCabe for performance year 2024, reported as part of a group. Dr. McCabe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McCabe as offering telehealth.

Dmand AI links 6 papers to Dr. McCabe, published from 2008 to 2023. Dr. McCabe's most frequent co-authors are Bradley Walters Frazee, MD, Colin M. Feeney, MD and Amarinder Singh, MD.

CMS Open Payments shows 7 general payments to Dr. McCabe from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $340.

Dr. McCabe graduated from Harvard Medical School in 1976.

Dr. McCabe is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.